EMCDDA provides the EU and its Member States with a factual overview of European drug problems and a solid evidence base to support the drugs debate. Today, it offers policymakers the data they need for drawing up informed drug laws and strategies. It also helps professionals and practitioners working in the field pinpoint best practice and new areas of research.